Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: eico20 who wrote (1730)	3/7/2016 10:57:06 PM
From: mokelumne river	Read Replies (1) of 2026

Thank you so much Eman. You have shed a lot of light for me on what is going on with RTD, US rights and Vitaros sales in the EU. Pascoe's sales target of 500K units of Vitaros a quarter in the EU would yield $5M in annual royalty profit, assuming a profit of $2.50 per unit (I am just guessing). $5M is nothing to sneeze at...but three to four times that is where I was hoping we would be by now. $15M - $20M annually is what the company really needs to offset annual costs in a meaningful way. You are so right that Sprout owners Cindy and her hubby fleeced Valeant royally.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next